Resinco Capital Partners Makes First Investment in Cannabis Pharma Sector

Resinco Capital Partners Makes First Investment in Cannabis Pharma Sector

VANCOUVER, British Columbia, Oct. 19, 2018 (GLOBE NEWSWIRE) — Resinco Capital Partners Inc. (CSE:RIN) (the “Company” or “Resinco”) announces that it has made an investment in Toronto, Ontario and Palo Alto, California based Cannabis Pharma company Katexco Pharmaceuticals Corp. The Company has now made its first investment in the Cannabis Pharma Sector with its investment […]

Wyoming sues Purdue Pharma over opioid marketing practices

Wyoming sues Purdue Pharma over opioid marketing practices

CASPER, Wyo. (AP) – The Wyoming Attorney General’s Office is suing the maker of OxyContin, claiming the pharmaceutical company deceptively marketed opioid painkillers in the state. The Casper Star-Tribune reports the state filed the lawsuit Thursday in Laramie County Circuit Court against Purdue Pharma, accusing the company of misrepresenting the risks and benefits of drugs. […]

Brainstorm Health: Pharma CEOs' Midterm Money, Parker Institute Investment, Merck Pfizer Combo Treatment

Brainstorm Health: Pharma CEOs' Midterm Money, Parker Institute Investment, Merck Pfizer Combo Treatment

Happy Friday, readers! This is Sy. The pharmaceutical industry has persistently been one of the biggest sources of political money in the country—perhaps unsurprising given the billions upon billions of dollars potentially affected by government policy. Drug companies and their allied trade groups pour buckets of funds into specific policy fights. For instance, the industry […]

Merrimack Pharma Halts Lung Cancer Trial; Stock Plunges More Than 32%

Merrimack Pharma Halts Lung Cancer Trial; Stock Plunges More Than 32%

Merrimack Pharmaceuticals’ stock plunged more than 32 percent after the company announced it was terminating its SHERLOC Phase II clinical trial. The trial was evaluating MM-121 in combination with docetaxel, a chemotherapy drug, in patients with heregulin positive non-small cell lung cancer (NSCLC). The company and the chair of the independent Data Safety Monitoring Board […]

FSD Pharma Comments on Recent Promotional Activity Pursuant to OTC Markets Request

FSD Pharma Comments on Recent Promotional Activity Pursuant to OTC Markets Request

TORONTO–(BUSINESS WIRE)–FSD Pharma Inc. (“FSD Pharma” or the “Company) (OTCQB: FSDDF), today announced that it has implemented an expanded shareholder communications initiative to provide greater transparency into the Company’s business plans and growth strategy. “The Company plans to communicate more effectively with shareholders on an ongoing basis in order to supply relevant company information,” said Zeeshan Saeed, […]

Nike CIO departs to join pharma giant Merck

Nike CIO departs to join pharma giant Merck

Brief Dive Brief: Nike CIO Jim Scholefield is leaving the athletic retailer and joining pharmaceutical company Merck as chief information and digital officer at the end of October, according to a company announcement earlier this week.  Scholefield has served as global CIO at Nike for almost three and a half years. Previously he worked as CTO […]

What the TV pricing disclosure proposal means to US pharma marketers

What the TV pricing disclosure proposal means to US pharma marketers

The pharma industry is scrambling after a proposal that would require pharma companies to disclose list prices for drugs in television commercials has been put forth by the US Department of Health and Human Services. The US is one of just two countries that allows pharma companies to market direct-to-consumer (DTC), and television has historically […]

The Shaming of Big Pharma

The Shaming of Big Pharma

Since the release of President Trump’s “Blueprint to Lower Drug Prices” this spring, there has been chatter about the Trump Administration requiring drug manufacturers to publicize the list price of their medications in direct-to-consumer (DTC) advertising. Sensing that the administration was ready to move on such a proposal, the Pharmaceutical Research and Manufacturers of America […]

Five things for pharma marketers to know: Friday, October 19, 2018

Five things for pharma marketers to know: Friday, October 19, 2018

The FDA is considering banning e-cigarette sales in convenience stores to curb teen use. The move would make e-cigarettes only available in vape shops. Commissioner Scott Gottlieb said many teens are illegally buying e-cigs in convenience stores, and the vape shops “do a better job of checking ID.” (CNBC) AbbVie settled a biosimilar patent dispute […]

Biotech Analysis Central Pharma News: Regeneron's Results, Bristol-Myers' Failure, Novartis' FDA Rejection

Biotech Analysis Central Pharma News: Regeneron's Results, Bristol-Myers' Failure, Novartis' FDA Rejection

Welcome to Biotech Analysis Central Daily News, a daily news report and analysis about what has happened lately in the biotech industry. Regeneron And Sanofi Obtain Positive Phase 3 Results With Dupixent News: Recently, Regeneron Pharmaceuticals (REGN) and Sanofi (SNY) announced that they had obtained positive results from a phase 3 study. The phase 3 […]